GHK-Cu: Copper-Binding Tripeptide in Cellular and Wound Research

Classification

Copper-Binding Tripeptide / Matrikine

Molecular Formula

C₁₈H₃₀N₆O₄Cu

Molecular Weight

~476 Da (Cu complex), ~340 Da (free peptide)

Sequence

Gly-His-Lys (GHK)

Ion Coordination

Cu²⁺ (copper ion)

Year First Isolated

1973

Research Focus

Wound healing, tissue regeneration, collagen synthesis, antioxidant activity

Introduction

GHK-Cu (glycyl-L-histidyl-L-lysine-copper(II)) is a naturally occurring tripeptide-copper complex first isolated from human plasma by Pickart and colleagues in 1973 (Pickart & Thaler, 1973).

The peptide itself, GHK (Gly-His-Lys), is a high-affinity copper-binding sequence that is released from proteins such as albumin and SPARC (secreted protein acidic and rich in cysteine) through proteolytic cleavage.

Once bound to copper, the GHK-Cu complex exhibits a wide range of biological activities that have made it one of the most extensively studied copper-binding peptides in the literature.

For researchers working with GHK-Cu and other copper-binding peptides, high-purity research compounds with comprehensive analytical documentation are available through RPL Peptides.

Research on GHK-Cu has spanned more than five decades, with investigations demonstrating effects on wound healing, tissue regeneration, collagen metabolism, antioxidant defense, and cellular signaling. The peptide is classified as a matrikine—a matrix-derived signaling molecule that regulates cellular responses and tissue repair processes.

GHK-Cu is also notable for its influence on gene expression, with studies reporting that it can modulate the expression of a substantial number of genes involved in tissue remodeling and cellular homeostasis (Pickart et al., 2015).

Molecular Characteristics

GHK-Cu is a tripeptide composed of the amino acids glycine, histidine, and lysine in sequence (Gly-His-Lys). The peptide acts as a chelator for copper(II) ions, forming a stable coordination complex with a 1:1 stoichiometry. The copper ion is coordinated by the terminal amino group, the deprotonated amide nitrogen of the peptide bond between Gly and His, and the imidazole nitrogen of the histidine side chain, creating a square-planar geometry around the metal center (Pickart & Thaler, 1973). The copper coordination geometry is critical for the biological activity of GHK-Cu. The free peptide (without copper) has significantly different biological properties compared to the copper-bound form, and the copper complex is considered the biologically active species.

The formation constant of the GHK-Cu complex is high (log K ≈ 16), reflecting very strong binding that allows the peptide to compete effectively for copper ions in biological fluids (Lau & Sarkar, 1975).

Detailed molecular characterization data for GHK-Cu and similar research peptides can be accessed through the RPL Peptides Data Center. GHK is generated endogenously through the proteolytic degradation of larger proteins, particularly albumin and SPARC.

In human plasma, GHK-Cu exists at concentrations of approximately 200 μg/L in young adults, though levels decline significantly with age. The plasma concentration of GHK has been reported to decrease by more than 60% between the ages of 20 and 60, a decline that correlates with age-related changes in tissue repair capacity (Pickart et al., 2015).

Biological Research Background

The discovery of GHK-Cu originated from investigations into factors that influence wound healing and tissue regeneration. Pickart and Thaler (1973) identified a small peptide in human plasma that could stimulate the healing of wounds in animal models. Subsequent purification and characterization revealed the active factor to be a copper complex of the tripeptide Gly-His-Lys. This discovery established the foundation for decades of research into the biological roles of GHK-Cu.

Mechanism of Action

GHK-Cu exerts its biological effects through multiple interconnected mechanisms:

• Gene Expression Modulation: GHK-Cu has been shown to alter the expression of a broad set of genes involved in extracellular matrix remodeling, including collagens, matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs).

Microarray studies have reported that GHK-Cu can influence the expression of more than 4,000 genes in human fibroblasts, with a general pattern of suppressing pro-inflammatory genes and promoting matrix synthesis (Gruber et al., 2006). - Collagen Synthesis: One of the most well-documented effects of GHK-Cu is its ability to stimulate collagen synthesis in fibroblasts.

Studies have reported increased production of collagen types I, III, and V in dermal fibroblasts following GHK-Cu treatment, with corresponding improvements in wound tensile strength in animal models (Maquart et al., 1988). - Copper Transport: GHK-Cu serves as a physiological copper transport system, delivering copper to cells for incorporation into copper-dependent enzymes, including superoxide dismutase (SOD), lysyl oxidase, and cytochrome c oxidase. - Antioxidant Activity: The GHK-Cu complex possesses superoxide dismutase-like activity, functioning as an antioxidant by catalyzing the dismutation of superoxide radicals.

This activity contributes to its cytoprotective effects in various cellular stress models (Pickart et al., 2015). - Cell Migration: GHK-Cu has been shown to promote the migration of fibroblasts, keratinocytes, and endothelial cells, processes that are essential for wound healing and tissue regeneration.

Current Research Landscape

Research on GHK-Cu continues to be active across multiple disciplines, reflecting the peptide's diverse biological activities. Researchers investigating tissue regeneration and wound healing may also find relevant information in the peptide stability studies and related analytical methods. Current research areas include:

• Wound Healing and Regenerative Medicine: Ongoing studies continue to explore GHK-Cu's effects on wound closure, angiogenesis, and tissue repair in various wound models, including diabetic wounds and chronic ulcers (Arul et al., 2007).
• Dermal Biology: Research on GHK-Cu in skin biology has expanded to include studies on dermal fibroblast function, extracellular matrix remodeling, and photoaging.

The peptide is among the most studied copper peptides in dermatological research. - Neurobiology: Emerging research has explored GHK-Cu effects in neural contexts.

Studies have reported that GHK-Cu can protect neuronal cells from oxidative stress and promote neurite outgrowth, suggesting potential relevance to neuroregeneration research. - Inflammation and Fibrosis: The anti-inflammatory properties of GHK-Cu have been investigated in models of fibrosis and chronic inflammation, with studies reporting modulation of TGF-β1 signaling and reduction of pro-fibrotic markers. - Cancer Research: Some studies have examined the effects of GHK-Cu on cancer cell behavior, though findings have been context-dependent and further research is required to clarify these relationships.

For experimental planning and research support, the RPL Peptides Research Tools platform provides peptide calculators and utilities for researchers working with copper-binding peptides and tissue regeneration studies.

Research Status: GHK-Cu is widely used in research as a model copper-binding peptide and is also available in some topical cosmetic preparations. It is not approved as a pharmaceutical drug by the FDA, EMA, or other regulatory agencies for therapeutic indications. All information is presented for educational and research informational purposes.

Related Research

BPC-157 Research Profile

Tissue repair and regenerative peptide research.

Cell Biology Research

Cellular research on copper-binding and regenerative peptides.

SS-31 Research Profile

Mitochondrial peptide for cellular bioenergetics research.

Frequently Asked Questions

Is GHK-Cu found naturally in the human body? +

Yes, GHK-Cu is a naturally occurring peptide-copper complex found in human plasma. It is generated through the proteolytic degradation of larger proteins, particularly albumin and SPARC (secreted protein acidic and rich in cysteine). Plasma levels of GHK-Cu are approximately 200 μg/L in healthy young adults but decline significantly with age.

How does GHK-Cu bind to copper? +

GHK binds copper(II) with high affinity through a square-planar coordination geometry. The copper ion is coordinated by three nitrogen donors: the N-terminal amino group of glycine, the deprotonated amide nitrogen of the first peptide bond, and the imidazole side chain of histidine. This creates a very stable complex with a dissociation constant in the femtomolar range.

What is the primary research focus for GHK-Cu? +

The primary research focus is wound healing and tissue regeneration. GHK-Cu has been extensively studied for its ability to stimulate collagen synthesis, promote fibroblast and keratinocyte migration, enhance angiogenesis, and modulate extracellular matrix remodeling. It is also investigated for its antioxidant properties and its role as a physiological copper transport system.

Does GHK-Cu affect gene expression? +

Yes, GHK-Cu has been shown to modulate the expression of a large number of genes. Microarray studies have reported that GHK-Cu can influence the expression of over 4,000 genes in human dermal fibroblasts. The general pattern is suppression of pro-inflammatory genes and upregulation of genes involved in extracellular matrix synthesis, antioxidant defense, and tissue remodeling.

Is GHK-Cu activity the same with and without copper? +

No, the biological activity of GHK-Cu differs significantly from the free GHK peptide. The copper-bound form is generally considered the biologically active species, and the metal coordination is essential for many of the peptide's reported biological effects, including its wound-healing and gene-modulating activities. The free peptide (without copper) has different properties and lower activity in most biological assays.

Has GHK-Cu been studied in humans? +

Yes, GHK-Cu has been studied in human research, primarily in the context of topical application for dermatological purposes. Clinical studies have examined its effects on skin appearance, wound healing, and hair growth. However, GHK-Cu has not been approved as a pharmaceutical drug for any medical indication and is primarily classified as a research chemical and cosmetic ingredient.

What is GHK-Cu's role in copper transport? +

GHK-Cu functions as a physiological copper delivery system in the body. It can bind and transport copper ions to cells, where the copper is incorporated into essential cuproenzymes such as superoxide dismutase (SOD1), lysyl oxidase (required for collagen and elastin crosslinking), and cytochrome c oxidase (involved in mitochondrial respiration). This copper-delivery function is a key part of GHK-Cu's biological mechanism.

About RPL Peptides: RPL Peptides is a supplier of high-purity research peptides with comprehensive analytical documentation including HPLC, LC-MS, and Certificates of Analysis (COA). For researchers requiring certified reference materials for laboratory investigations, visit rplpeptides.com or explore detailed molecular data at the RPL Peptides Data Center.

References

1. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology. 1973;243(126):87-88. doi:10.1038/newbio243085a0
2. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive decline. Oxidative Medicine and Cellular Longevity. 2012;2012:324832. doi:10.1155/2012/324832
3. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2015;16(12):28568-28579. doi:10.3390/ijms161226114
4. Gruber JV, Holtz R, Kadla JE, et al. Effects of the copper tripeptide complex (GHK-Cu) on gene expression in adult human dermal fibroblasts. Journal of the American Academy of Dermatology. 2006;54(3):AB44.
5. Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by a tripeptide-copper complex. FEBS Letters. 1988;238(2):343-346. doi:10.1016/0014-5793(88)80509-4
6. Lau SJ, Sarkar B. Ternary coordination complex between human serum albumin, copper(II), and L-histidine. Journal of Biological Chemistry. 1975;250(12):4592-4596.
7. Arul V, Kartha R, Jayakumar R. A therapeutic approach for diabetic wound healing using biopolymers and GHK-Cu. Biomaterials. 2007;28(2):332-340. doi:10.1016/j.biomaterials.2006.08.037
8. Pickart L. The human tripeptide GHK-Cu and cellular signaling. Advances in Wound Care. 2015;4(1):41-52. doi:10.1089/wound.2014.0542
9. Wayner MJ, Nozik-Grayck E, Piantadosi CA. The copper-binding peptide GHK as a superoxide dismutase mimic. Free Radical Biology and Medicine. 2001;31(5):656-666. doi:10.1016/S0891-5849(01)00636-5
10. Hutchinson LB, McClinton R, Hagger C, et al. The copper-binding tripeptide GHK-Cu promotes wound healing in murine models. Wound Repair and Regeneration. 2004;12(1):A2.